These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21918740)

  • 1. [Treatment and prevention of infections in cancer patients with neutropenia].
    Sinkó J
    Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the febrile neutropenic patient with cancer.
    Gucalp R
    Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN: Fever and neutropenia.
    Wade JC; Rubenstein EB;
    Cancer Control; 2001; 8(6 Suppl 2):16-21. PubMed ID: 11760554
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
    Masaoka T
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
    [No Abstract]   [Full Text] [Related]  

  • 9. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI; Ribeiro Kde C; de Camargo B
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
    Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
    Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E; Lange BJ
    Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.
    Lingaratnam S; Slavin MA; Koczwara B; Seymour JF; Szer J; Underhill C; Prince M; Mileshkin L; O'Reilly M; Kirsa SW; Bennett CA; Davis ID; Morrissey O; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):75-81. PubMed ID: 21272171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient oral antibiotics for febrile neutropenic cancer patients.
    Ouvrier MJ; Thery JC; Blot E
    J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
    [No Abstract]   [Full Text] [Related]  

  • 14. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M; Carratala J
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Empirical antimicrobial therapy in a patient with neutropenia].
    Anttila VJ; Ruotsalainen E
    Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.